Vimta Labs revenue rose 10% as September profit grew 3.5%

Vimta Labs Limited reported revenue from operations of Rs 111.983 crore for the quarter ended September 30, 2026, up 9.95% from Rs 101.848 crore a year earlier. Net profit rose 3.48% to Rs 20.614 crore, while total expenses increased 11.67%, led by higher testing expenditure, employee benefits and depreciation.

How did Vimta Labs perform in the September 2026 quarter?

Vimta Labs increased total income by 9.93% to Rs 114.887 crore in the quarter ended September 30, 2026, from Rs 104.506 crore in the corresponding quarter of 2025. Revenue from operations accounted for Rs 111.983 crore of the latest-quarter total, while other income was Rs 2.904 crore, compared with Rs 2.658 crore a year earlier.

Profit before tax rose 4.76% to Rs 27.525 crore from Rs 26.274 crore, a slower increase than revenue from operations. After tax expense of Rs 6.911 crore, net profit was Rs 20.614 crore versus Rs 19.920 crore in the September 2025 quarter. Basic earnings per share, or EPS, increased to Rs 4.61 from Rs 4.46, while diluted EPS rose to Rs 4.57 from Rs 4.44.

Why did Vimta Labs profit rise more slowly than revenue?

Vimta Labs' profit rose more slowly because total expenses increased 11.67% to Rs 87.362 crore in the September 2026 quarter, exceeding the 9.95% growth in revenue from operations. The increase in operating revenue was Rs 10.135 crore year on year, while profit before tax increased by Rs 1.251 crore.

Cost of materials consumed and testing expenditure rose by Rs 6.018 crore to Rs 26.152 crore from Rs 20.134 crore. Employee benefits expense increased by Rs 2.054 crore to Rs 30.667 crore, and depreciation and amortisation rose by Rs 2.628 crore to Rs 12.868 crore. These three cost categories together increased by Rs 10.700 crore from the September 2025 quarter.

Other expenses declined by Rs 1.568 crore to Rs 17.290 crore, partly offsetting the higher testing, employee and depreciation costs. Finance costs were Rs 0.385 crore against Rs 0.374 crore a year earlier, while total tax expense rose to Rs 6.911 crore from Rs 6.354 crore. The reported figures show that cost growth was higher than revenue growth during the quarter.

How did Vimta Labs compare with the June 2026 quarter?

Vimta Labs increased revenue from operations by 2.67% from Rs 109.074 crore in the quarter ended June 30, 2026 to Rs 111.983 crore in the September quarter. Total income, however, increased by 1.77% to Rs 114.887 crore because other income declined to Rs 2.904 crore from Rs 3.812 crore.

Net profit fell 2.03% sequentially to Rs 20.614 crore from Rs 21.042 crore, despite the increase in operating revenue. Profit before tax declined to Rs 27.525 crore from Rs 28.338 crore as total expenses rose to Rs 87.362 crore from Rs 84.548 crore. Basic EPS accordingly declined from Rs 4.71 to Rs 4.61.

Testing expenditure increased by Rs 3.525 crore from the June quarter to Rs 26.152 crore in September, while employee benefits expense rose by Rs 1.247 crore to Rs 30.667 crore. Depreciation and amortisation increased by Rs 0.320 crore to Rs 12.868 crore, whereas other expenses fell by Rs 2.381 crore to Rs 17.290 crore.

What were Vimta Labs' half-year results?

Vimta Labs reported revenue from operations of Rs 221.057 crore for the half year ended September 30, 2026, up 10.85% from Rs 199.412 crore in the corresponding 2025 half year. Total income rose to Rs 227.773 crore from Rs 203.819 crore over the same periods.

Half-year net profit increased 7.32% to Rs 41.656 crore from Rs 38.813 crore, while profit before tax rose 8.40% to Rs 55.863 crore from Rs 51.535 crore. Total expenses increased 12.89% to Rs 171.910 crore from Rs 152.284 crore, again exceeding the rate of revenue growth.

For the six months, materials consumed and testing expenditure rose to Rs 48.779 crore from Rs 38.933 crore, employee benefits expense increased to Rs 60.087 crore from Rs 56.431 crore, and depreciation and amortisation reached Rs 25.416 crore from Rs 20.102 crore. Basic half-year EPS was Rs 9.32, compared with Rs 8.71 in the prior-year half.

What business, accounting and corporate items did Vimta Labs disclose?

Vimta Labs identified Contract Research and Testing Services as its sole reportable segment under Indian Accounting Standard 108, or Ind AS 108. The filing therefore does not provide a revenue or profit split within the Rs 111.983 crore of September-quarter operating revenue.

The company disclosed that its June 29, 2021 public-private partnership agreement with the Food Safety and Standards Authority of India is treated as a service concession arrangement. Revenue from lab setup services and the related expense were nil in the September 2026 quarter, compared with Rs 0.013 crore in September 2025 and Rs 0.045 crore in June 2026.

Employee benefits expense included Rs 0.943 crore of share-based payment cost in the September 2026 quarter, compared with Rs 1.662 crore a year earlier. The nomination and remuneration committee granted 14,000 options under the Vimta Labs Employee Stock Option Plan 2021 on October 26, 2026. On October 30, 2026, the board also took note of the incorporation of Vimta Labs LLC as a wholly owned subsidiary in the United States.

Conclusion

Vimta Labs delivered year-on-year operating revenue growth of 9.95% in the September 2026 quarter, but net profit growth was 3.48% as total expenses rose 11.67%. The half-year pattern was similar: revenue from operations grew 10.85%, while expenses increased 12.89%, limiting the increase in half-year profit to 7.32%.

The next disclosed matter to watch is Vimta Labs LLC, whose incorporation the board noted on October 30, 2026. The filing does not disclose an investment amount, operating timetable, target or expected revenue contribution for the US subsidiary, while the 14,000 options granted on October 26, 2026 will be recognised as employee compensation expense over their vesting period.